101 related articles for article (PubMed ID: 29588513)
1. Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.
Joseph C; Macnamara O; Craze M; Russell R; Provenzano E; Nolan CC; Diez-Rodriguez M; Sonbul SN; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Mukherjee A
Br J Cancer; 2018 Apr; 118(8):1142-1151. PubMed ID: 29588513
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.
Aleskandarany MA; Abduljabbar R; Ashankyty I; Elmouna A; Jerjees D; Ali S; Buluwela L; Diez-Rodriguez M; Caldas C; Green AR; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Sep; 159(2):215-27. PubMed ID: 27514395
[TBL] [Abstract][Full Text] [Related]
3. The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.
El Ansari R; Craze ML; Miligy I; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res; 2018 Mar; 20(1):21. PubMed ID: 29566741
[TBL] [Abstract][Full Text] [Related]
4. Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.
Aleskandarany MA; Sonbul S; Surridge R; Mukherjee A; Caldas C; Diez-Rodriguez M; Ashankyty I; Albrahim KI; Elmouna AM; Aneja R; Martin SG; Ellis IO; Green AR; Rakha EA
Br J Cancer; 2017 Oct; 117(8):1176-1184. PubMed ID: 28829761
[TBL] [Abstract][Full Text] [Related]
5. DACH1: its role as a classifier of long term good prognosis in luminal breast cancer.
Powe DG; Dhondalay GK; Lemetre C; Allen T; Habashy HO; Ellis IO; Rees R; Ball GR
PLoS One; 2014; 9(1):e84428. PubMed ID: 24392136
[TBL] [Abstract][Full Text] [Related]
6. MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours.
Green AR; Aleskandarany MA; Agarwal D; Elsheikh S; Nolan CC; Diez-Rodriguez M; Macmillan RD; Ball GR; Caldas C; Madhusudan S; Ellis IO; Rakha EA
Br J Cancer; 2016 Apr; 114(8):917-28. PubMed ID: 26954716
[TBL] [Abstract][Full Text] [Related]
7. A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
Kurozumi S; Joseph C; Sonbul S; Alsaeed S; Kariri Y; Aljohani A; Raafat S; Alsaleem M; Ogden A; Johnston SJ; Aleskandarany MA; Fujii T; Shirabe K; Caldas C; Ashankyty I; Dalton L; Ellis IO; Desmedt C; Green AR; Mongan NP; Rakha EA
Br J Cancer; 2019 Jun; 120(12):1129-1136. PubMed ID: 31114020
[TBL] [Abstract][Full Text] [Related]
8. High Inner Centromere Protein Expression Correlates with Aggressive Features and Predicts Poor Prognosis in Patients with Invasive Breast Cancer.
Ibrahim A; Miligy IM; Toss MS; Green AR; Rakha EA
Pathobiology; 2023; 90(6):377-388. PubMed ID: 37031675
[TBL] [Abstract][Full Text] [Related]
9. B-Cell-Mediated Immunity Predicts Survival of Patients With Estrogen Receptor-Positive Breast Cancer.
Lee S; Kang BH; Lee HB; Jang BS; Han W; Kim IA
JCO Precis Oncol; 2024 Mar; 8():e2300263. PubMed ID: 38452311
[TBL] [Abstract][Full Text] [Related]
10. LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA).
Jin TY; Saindane M; Park KS; Kim S; Nam S; Yoo Y; Yang JH; Yun I
Medicine (Baltimore); 2021 Aug; 100(33):e26896. PubMed ID: 34414945
[TBL] [Abstract][Full Text] [Related]
11. Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.
Rakha EA; Soria D; Green AR; Lemetre C; Powe DG; Nolan CC; Garibaldi JM; Ball G; Ellis IO
Br J Cancer; 2014 Apr; 110(7):1688-97. PubMed ID: 24619074
[TBL] [Abstract][Full Text] [Related]
12. Copper Chaperone for Superoxide Dismutase Subtypes as a Prognostic Marker in Luminal B Breast Cancer.
Li Y; Du W; Yang R; Wei X; Li H; Zhang X
Clin Med Insights Oncol; 2024; 18():11795549231219239. PubMed ID: 38187458
[TBL] [Abstract][Full Text] [Related]
13. Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance.
Makhlouf S; Quinn C; Toss M; Alsaleem M; Atallah NM; Ibrahim A; Rutland CS; Mongan NP; Rakha EA
Eur J Cancer; 2024 Jan; 197():113473. PubMed ID: 38103327
[TBL] [Abstract][Full Text] [Related]
14. High Atlastin 2-2 (ATL2-2) Expression Associates with Worse Prognosis in Estrogen-Receptor-Positive Breast Cancer.
Reynisdottir I; Arason A; Freysteinsdottir ES; Kristjansdottir SB; Hilmarsdottir B; Traustadottir GA; Johannsson OT; Agnarsson BA; Barkardottir RB
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628611
[TBL] [Abstract][Full Text] [Related]
15. Lactate concentration in breast cancer using advanced magnetic resonance spectroscopy.
Cheung SM; Husain E; Masannat Y; Miller ID; Wahle K; Heys SD; He J
Br J Cancer; 2020 Jul; 123(2):261-267. PubMed ID: 32424149
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening.
Ruiz-Garcia E; Scott V; Machavoine C; Bidart JM; Lacroix L; Delaloge S; Andre F
Br J Cancer; 2010 Feb; 102(3):462-8. PubMed ID: 20068563
[TBL] [Abstract][Full Text] [Related]
17. AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancer.
Wahab N; Toss M; Miligy IM; Jahanifar M; Atallah NM; Lu W; Graham S; Bilal M; Bhalerao A; Lashen AG; Makhlouf S; Ibrahim AY; Snead D; Minhas F; Raza SEA; Rakha E; Rajpoot N
NPJ Precis Oncol; 2023 Nov; 7(1):122. PubMed ID: 37968376
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the Morphology of Tumor-Stromal Features in Invasive Breast Cancer Using Artificial Intelligence.
Atallah NM; Wahab N; Toss MS; Makhlouf S; Ibrahim AY; Lashen AG; Ghannam S; Mongan NP; Jahanifar M; Graham S; Bilal M; Bhalerao A; Ahmed Raza SE; Snead D; Minhas F; Rajpoot N; Rakha E
Mod Pathol; 2023 Oct; 36(10):100254. PubMed ID: 37380057
[TBL] [Abstract][Full Text] [Related]
19. ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Estrogen Receptor Positive Breast Cancer.
Patel R; Alfarsi LH; El-Ansari R; Masisi BK; Erkan B; Fakroun A; Ellis IO; Rakha EA; Green AR
Pathobiology; 2024 Jun; ():. PubMed ID: 38861938
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.
Kurozumi S; Joseph C; Sonbul S; Gorringe KL; Pigera M; Aleskandarany MA; Diez-Rodriguez M; Nolan CC; Fujii T; Shirabe K; Kuwano H; Storr S; Martin SG; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2018 Aug; 170(3):525-533. PubMed ID: 29633055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
